Twin Focus Capital Partners LLC Invests $443,000 in iShares Biotechnology ETF $IBB

Twin Focus Capital Partners LLC purchased a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,066 shares of the financial services provider’s stock, valued at approximately $443,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth $201,000. AQR Capital Management LLC purchased a new stake in iShares Biotechnology ETF in the first quarter valued at approximately $455,000. Millennium Management LLC raised its position in shares of iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after buying an additional 143,893 shares in the last quarter. Envestnet Asset Management Inc. grew its position in iShares Biotechnology ETF by 5.8% in the second quarter. Envestnet Asset Management Inc. now owns 56,079 shares of the financial services provider’s stock worth $7,095,000 after acquiring an additional 3,051 shares in the last quarter. Finally, TIAA Trust National Association raised its position in iShares Biotechnology ETF by 4.6% during the second quarter. TIAA Trust National Association now owns 3,486 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 153 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.7%

Shares of iShares Biotechnology ETF stock opened at $172.97 on Thursday. The business’s 50-day moving average price is $172.85 and its 200-day moving average price is $161.05. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were paid a $0.1831 dividend. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.